Lawrence Klein is partner based in the San Francisco Bay Area. He previously was a critical member of the CRISPR Therapeutics leadership team and helped grow the company into one of the most recognized innovative biotechs in the industry. With this experience, he is very well-positioned to identify the most promising opportunities in a wide range of fields, and to partner with founders and executive teams on accelerating company building and growth.
During Lawrence’s tenure with Crispr, he served as Chief Business Officer before also taking on the role of Chief Operating Officer. In these roles he helped to initiate and execute on several transformative partnerships, establish the strategic direction of the company, oversee important pipeline programs, and contribute to building the team.
Lawrence holds a Ph.D. in biophysics from Stanford University.